Erik Sahai Selected Research

Erik Sahai Research Topics

Disease

41	Neoplasms (Cancer) 01/2024 - 02/2002
13	Neoplasm Metastasis (Metastasis) 01/2024 - 03/2005
12	Melanoma (Melanoma, Malignant) 01/2022 - 10/2008
7	Breast Neoplasms (Breast Cancer) 03/2021 - 06/2005
6	Carcinoma (Carcinomatosis) 03/2013 - 07/2003
2	Brain Neoplasms (Brain Tumor) 01/2022 - 09/2020
2	Infections 11/2021 - 01/2019
2	Bites and Stings (Sting) 07/2020 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 06/2007
2	Inflammation (Inflammations) 09/2015 - 08/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2011 - 12/2007
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Fibrosarcoma 01/2022
1	Phototoxic Dermatitis (Phototoxicity) 12/2019
1	Carcinogenesis 01/2018
1	Rupture 01/2017
1	Genomic Instability 01/2017
1	Hypoxia (Hypoxemia) 10/2015
1	Autoimmune Diseases (Autoimmune Disease) 09/2015
1	Colorectal Neoplasms (Colorectal Cancer) 09/2015
1	Cysts 02/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2013
1	Glioblastoma (Glioblastoma Multiforme) 02/2012
1	Hypopigmentation (Hypomelanosis) 10/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2002
6	ActomyosinIBA 01/2017 - 08/2006
4	CollagenIBA 01/2016 - 05/2005
4	Phosphotransferases (Kinase)IBA 09/2015 - 12/2004
3	Cadherins (E-Cadherin)IBA 01/2018 - 05/2013
3	rho-Associated KinasesIBA 01/2016 - 01/2007
3	Small Interfering RNA (siRNA)IBA 02/2014 - 02/2012
3	Transforming Growth Factor beta (TGF-beta)IBA 05/2010 - 10/2009
3	Epidermal Growth Factor (EGF)IBA 12/2008 - 06/2005
3	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2007 - 02/2002
2	Actins (F Actin)IBA 01/2022 - 12/2004
2	PLX 4720IBA 01/2022 - 04/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2018
2	ChemokinesIBA 11/2021 - 01/2018
2	chenodeoxycholate sulfate conjugate (CDCS)IBA 11/2021 - 01/2019
2	Estrogen ReceptorsIBA 03/2021 - 12/2004
2	CytokinesIBA 01/2020 - 08/2011
2	Dinoprostone (PGE2)FDA Link 01/2018 - 09/2015
2	IntegrinsIBA 04/2015 - 12/2007
2	GTP Phosphohydrolases (GTPases)IBA 02/2012 - 10/2008
2	Transcription Factors (Transcription Factor)IBA 01/2011 - 03/2009
2	Green Fluorescent ProteinsIBA 10/2009 - 05/2005
2	Myosins (Myosin)IBA 02/2008 - 08/2006
2	Peptide Hydrolases (Proteases)FDA Link 12/2007 - 08/2006
2	Carrier Proteins (Binding Protein)IBA 12/2007 - 06/2007
2	ErbB Receptors (EGF Receptor)IBA 01/2006 - 06/2005
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2024
1	RE1-silencing transcription factorIBA 01/2024
1	metabotropic glutamate receptor type 1IBA 01/2024
1	OvalbuminIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	GNE-317IBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	MethyltransferasesIBA 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	RNA (Ribonucleic Acid)IBA 09/2020
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 09/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	InterferonsIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	ChromatinIBA 01/2018
1	Chemotactic FactorsIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Complex MixturesIBA 07/2017
1	afadinIBA 01/2017
1	NectinsIBA 01/2017
1	AntioxidantsIBA 01/2016
1	VemurafenibIBA 01/2016
1	SeptinsIBA 12/2015
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2015
1	Myosin Type IIIBA 10/2015
1	PeriostinIBA 10/2015
1	Prostaglandin-E SynthasesIBA 09/2015
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2015
1	AT13148IBA 06/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2014
1	protein kinase C lambdaIBA 02/2014
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	CateninsIBA 05/2013
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 05/2013
1	AgarIBA 03/2013
1	Nonsense Codon (Nonsense Mutation)IBA 03/2013
1	CarcinogensIBA 03/2013
1	GelsIBA 02/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2011
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2011
1	Discoidin Domain Receptor 1IBA 01/2011
1	myocardinIBA 03/2009

Therapy/Procedure

12	Therapeutics 01/2022 - 03/2005
3	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
2	Radiotherapy 01/2022 - 07/2017
2	Immunotherapy 01/2020 - 01/2018
1	Anesthesia 12/2019
1	Intradermal Injections 06/2015